Option Care Health (NASDAQ:OPCH) Shares Up 5.6% – Still a Buy?

Option Care Health, Inc. (NASDAQ:OPCH)’s stock price shot up 5.6% during trading on Tuesday . The stock traded as high as $20.64 and last traded at $20.79. 1,794,971 shares traded hands during mid-day trading, a decline of 26% from the average session volume of 2,428,171 shares. The stock had previously closed at $19.69.

Analysts Set New Price Targets

Several brokerages recently commented on OPCH. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $26.00 price target on shares of Option Care Health in a research report on Friday, May 1st. Truist Financial set a $30.00 price target on shares of Option Care Health in a research report on Friday, May 1st. TD Cowen reduced their price target on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating for the company in a research report on Friday, May 1st. National Bank Financial set a $37.00 price target on shares of Option Care Health in a research report on Tuesday, January 27th. Finally, Wall Street Zen downgraded shares of Option Care Health from a “buy” rating to a “hold” rating in a research report on Saturday, February 28th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $31.25.

Option Care Health Trading Down 3.2%

The stock has a market cap of $3.38 billion, a price-to-earnings ratio of 16.68, a price-to-earnings-growth ratio of 1.16 and a beta of 0.68. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.07 and a current ratio of 1.64. The company’s 50 day simple moving average is $26.30 and its two-hundred day simple moving average is $30.12.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.03. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The company’s revenue for the quarter was up 1.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Research analysts expect that Option Care Health, Inc. will post 1.64 EPS for the current fiscal year.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, CEO John Charles Rademacher purchased 12,500 shares of the company’s stock in a transaction dated Monday, May 4th. The shares were bought at an average price of $21.18 per share, for a total transaction of $264,750.00. Following the purchase, the chief executive officer directly owned 695,152 shares in the company, valued at $14,723,319.36. This trade represents a 1.83% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Timothy P. Sullivan purchased 24,154 shares of the company’s stock in a transaction dated Thursday, May 7th. The shares were acquired at an average price of $20.69 per share, for a total transaction of $499,746.26. Following the purchase, the director owned 73,383 shares in the company, valued at $1,518,294.27. The trade was a 49.06% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders have purchased 73,264 shares of company stock worth $1,548,316. 1.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. V Square Quantitative Management LLC acquired a new position in shares of Option Care Health during the 4th quarter worth $25,000. Cornerstone Planning Group LLC increased its stake in shares of Option Care Health by 7,621.4% during the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after purchasing an additional 1,067 shares during the last quarter. Advisory Services Network LLC acquired a new position in shares of Option Care Health during the 3rd quarter worth $35,000. McIlrath & Eck LLC acquired a new position in shares of Option Care Health during the 2nd quarter worth $37,000. Finally, Caitong International Asset Management Co. Ltd acquired a new position in shares of Option Care Health during the 3rd quarter worth $38,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.